Study of CD388 for the Prevention of Influenza in Subjects Not at Risk for Influenza Complications
Public ClinicalTrials.gov record NCT06609460. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2b Randomized, Double-blind, Placebo-controlled, Multicenter Dose Ranging Study to Evaluate Efficacy and Safety of CD388, a Novel Long-acting Antiviral Conjugate, for the Prevention of Influenza in Subjects Not at Risk for Influenza Complications
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the effectiveness of CD388 in preventing symptomatic laboratory-confirmed influenza infections, as compared to placebo, and to select a dose of CD388 that is effective in preventing the same, when administered as a single dose via 3 subcutaneous (SQ) injections to adult participants in stable health, and to evaluate the safety and tolerability of CD388, as compared to placebo.
Study identification
- NCT ID
- NCT06609460
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
- Industry
- Enrollment
- 5,071 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 63 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 20, 2024 (Actual)
- Primary completion
- Oct 9, 2025 (Actual)
- Completion
- Oct 9, 2025 (Actual)
- Last update posted
- Jun 18, 2026
2024 – 2025
United States locations
- U.S. sites
- 56
- U.S. states
- 29
- U.S. cities
- 54
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pinnacle Research Group, LLC | Anniston | Alabama | 36207 | — |
| Cullman Clinical Trials | Cullman | Alabama | 35055 | — |
| Fiel Family and Sports Medicine/CCT Research | Tempe | Arizona | 85283 | — |
| Del Sol Research Management, LLC | Tucson | Arizona | 85715 | — |
| Baptist Health Center for Clinical Research | Little Rock | Arkansas | 72205 | — |
| Velocity Clinical Research - Huntington Park | Huntington Park | California | 90255 | — |
| Velocity Clinical Research - San Diego | La Mesa | California | 91942 | — |
| Catalina Research Institute, LLC | Montclair | California | 91763 | — |
| Profound Research LLC | Oceanside | California | 92058 | — |
| Acclaim Clinical Research | San Diego | California | 92120 | — |
| Lynn Institute of the Rockies | Colorado Springs | Colorado | 80918 | — |
| Critical Care, Pulmonary & Sleep Associates, PLLP/CCT Research | Lakewood | Colorado | 80228 | — |
| Alliance for Multispecialty Research, LLC | Fort Myers | Florida | 33912 | — |
| Nature Coast Clinical Research | Inverness | Florida | 34452 | — |
| Health Awareness, LLC | Jupiter | Florida | 33458 | — |
| South Florida Research Center, Inc. | Miami | Florida | 33135 | — |
| Clinical Site Partners, LLC dba Flourish Research | Miami | Florida | 33186 | — |
| Floridian Clinical Research | Miami Lakes | Florida | 33016 | — |
| Healthcare Clinical Data, Inc. | North Miami | Florida | 33161 | — |
| DelRicht Research | Atlanta | Georgia | 30329 | — |
| Velocity Clinical Research - Boise | Meridian | Idaho | 83642 | — |
| Optimal Research, LLC | Peoria | Illinois | 61614 | — |
| Velocity Clinical Research - Valparaiso | Valparaiso | Indiana | 46383 | — |
| Velocity Clinical Research - Sioux City | Sioux City | Iowa | 51106 | — |
| Johnson County Clin-Trials | Lenexa | Kansas | 66219 | — |
| DelRicht Research | Louisville | Kentucky | 40205 | — |
| IMA Clinical Research | Monroe | Louisiana | 71201 | — |
| DelRicht Research | New Orleans | Louisiana | 70115 | — |
| DelRicht Research | Prairieville | Louisiana | 70769 | — |
| Profound Research LLC | Clarkston | Michigan | 48346 | — |
| Profound Research LLC | Farmington Hills | Michigan | 48334 | — |
| Profound Research LLC | Rochester Hills | Michigan | 48307 | — |
| DelRicht Research | Gulfport | Mississippi | 39503 | — |
| DelRicht Research | Springfield | Missouri | 65807 | — |
| Sundance Clinical Research, LLC | St Louis | Missouri | 63141 | — |
| Velocity Clinical Research - Norfolk | Norfolk | Nebraska | 68701 | — |
| Velocity Clinical Research - Omaha | Omaha | Nebraska | 68134 | — |
| Velocity Clinical Research - Albuquerque | Albuquerque | New Mexico | 87107 | — |
| IMA Clinical Research | New York | New York | 10036 | — |
| DelRicht Research | Charlotte | North Carolina | 28205 | — |
| Velocity Clinical Research - Cleveland | Beachwood | Ohio | 44122 | — |
| Velocity Clinical Research - Springdale | Cincinnati | Ohio | 45246 | — |
| DelRicht Research | Tulsa | Oklahoma | 74133 | — |
| Velocity Clinical Research - Medford | Medford | Oregon | 97504 | — |
| Velocity Clinical Research - Anderson | Anderson | South Carolina | 29621 | — |
| DelRicht Research | Charleston | South Carolina | 29407 | — |
| Spartanburg Medical Research | Spartanburg | South Carolina | 29303 | — |
| DelRicht Research | Hendersonville | Tennessee | 37075 | — |
| Zenos Clinical Research | Dallas | Texas | 75230 | — |
| Lonestar Clinical Research, LLC | Dallas | Texas | 75243 | — |
| DelRicht Research | Prosper | Texas | 75078 | — |
| Clinical Trials of Texas, LLC dba Flourish Research | San Antonio | Texas | 78229 | — |
| Stephenville Medical & Surgical Clinic | Stephenville | Texas | 76401 | — |
| Alliance for Multispecialty Research, LLC | Layton | Utah | 84041 | — |
| Velocity Clinical Research - Salt Lake City | West Jordan | Utah | 84088 | — |
| Clinical Research Partners, LLC | Richmond | Virginia | 23226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06609460, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 18, 2026 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT06609460 live on ClinicalTrials.gov.